Scholar Commonsmetadata only
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease
circulating tumor dna (ctdna), minimal residual disease, breast cancer, ultrasensitive ctdna detection, neoadjuvant therapy, pathologic response, molecular residual disease, liquid biopsy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 410145
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.